Abstract
Photodynamic therapy (PDT) is a new approach to the local treatment of cancers. A photosensitizer, non-toxic in the dark, is administered to a patient. The photosensitizer is retained with some degree of selectivity by tumor tissue. On exposure to light of the appropriate wavelength, highly reactive but very short lived chemical species are produced which cause cell death. The short half life of these toxic species ensures that the cytotoxic effect is confined to the tissue exposed to the therapeutic light, thus avoiding systemic toxicity.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abulafi AM, Dean R, Allardice JT, Williams NS (1992) Prevention of cutaneous phototoxicity following photodynamic therapy ( Abstract ). Lasers Med Surg Suppl 4: 49
Auler H, Banzer G (1942) Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch 53: 65–68
Barr H, Chatlani P, Tralau CJ, MacRobert AJ, Boulos PB, Bown Sg (1991) Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue. Gut 32: 517–523
Barr H, Krasner N, Boulos PB, Chatlani P, Bown SG (1990) Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 77: 93–96
Bedwell J, Holton J, Vaira D, MacRobert AJ, Bown SG (1991) In vitro killing of Helicobacter pylori with photodynamic therapy. Lancet 335: 1287
Bedwell J, MacRobert AJ, Phillips D, Bown SG (1992) Fluorescence distribution and photo-dynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model. Br J Cancer 65: 818–824
Bugelski PJ, Porter CW, Dougherty TJ (1981) Autoradiographic distribution of hematoporphyrin derivative in normal and tumour tissue of the mouse. Cancer Res 41: 4606–4612
Chatlani PT, Bedwell J, MacRobert AJ, Bown SG (1992) Distribution and photodynamic effects of A1S2PC and AlS4Pc (di-and tetra- sulphonated aluminium phthalocyanine) in normal and neoplastic colon ( Abstract ). Lasers Med Sci 7: 229
Cowled PA, Forbes IJ (1985) Photocytotoxicity in vivo of haematoporphyrin derivative components. Cancer Lett 28: 111–118
Divans XG, Kennedy JC, Pottier RH (1990) Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localised protoporphyrin IX fluorescence. Am J Pathol 136: 891–897
Dougherty TJ (1990) Photodynamic therapy for the treatment of cancer: current status and advances. In: Kessel D (ed) Photodynamic therapy of neoplastic disease, vol 1. CRC Press, Boca Raton, pp 1–20
Figge FHJ, Weiland GS, Manganiello LOJ (1948) Cancer detection and therapy. Affinity of neoplastic, embryonic and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68: 640–641
Gomer CJ, Razum NJ (1984) Acute skin response in albino mice following prophyrin photo-sensitization under oxic and anoxic conditions. Photochem Photobiol 40: 435–439
Gomer CJ, Rucker N, Murphree AL (1988) Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res 48: 4539–4542
Hayata Y, Kato H, Konaka C et al. (1982) Hematoporphyrin derivative and laser photo-radiation in the treatment of lung cancer. Chest 81: 269–277
Ito Y, Kasugai T (1987) Use of endoscopic laser in gastroenterology. Ann Acad Med Sing 16: 290–293
Jesionek A, von Tappeiner H (1905) Zur Behandlung der Hautcarcinome mit fluorescierenden Stoffen. Arch Klin Med 82: 223
Jori G (1989) In vivo transport and pharmacokinetic behaviour of tumour photosensitizers. In: Photosensitizing compounds: their chemistry, biology and clinical use. Wiley, Chichester, pp 78–94
Kato H, Aizawa K, Ono J, Konaka C, Kawate N, Yoneyama K, Kinoshita K, Nishimiya K, Sakai H, Noguchi M, Tomono T, Kawasaki S, Tokuda Y, Hayata Y (1984) Clinical measurement of tumor fluorescence using a new diagnostic system with hematoporphyrin derivative, laser photoradiation, and a spectroscope. Lasers Surg Med 4: 49–58
Kato H, Kawaguchi M, Konoka C, Nishimiya K, Kawate M, Yoneyama K, Kinoshita K, Noguchi M, Ishii M, Shirai M, Hirano T, Aizawa K, Hayata Y (1985) Evaluation of photodynamic therapy in gastric cancer. Lasers Med Sci 1: 67–74
Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B: Biol 6: 143–148
Kessel D, Erickson C (1992) Porphyrin photosensitization of multi-drug resistant cell types. Photochem Photobiol 55: 397–399
Li JH, Guo ZH, Jin ML, Zhao FY, Cai WM, Gao ML, Shu My, Zou J (1990) Photodynamic therapy in the treatment of malignant tumours: an analysis of 540 cases. J Photochem Photobiol B: Biol 6: 149–155
Lipson RL, Baldes EJ (1960) The photodynamic property of a particular haematoporphyrin derivative. Arch Dermatol 82: 508–516
Lipson RL, Baldes EJ, Olsen AM (1961) Haematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 42: 623–629
Lipson RL, Baldes EJ, Olsen AM (1964) Further evaluation of the use of haematoporphyrin derivative as a new aid for endoscopic detection of malignant disease. Dis Chest 46: 676–679
Lipson RL, Baldes EJ, Gray MJ (1967) Haematoporphyrin derivative for the detection and management of cancer. Cancer 20: 2255–2257
Lipson RL, Baldes EJ, Olsen AM (1961) The use of a derivative of haematoporphyrin in tumour detection. J Natl Cancer Inst 26: 1–11
Lipson RL, Pratt JH, Baldes EJ (1964) Haematoporphyrin derivative for the detection of cervical cancer. Obstet Gynecol 24: 78
Loh CS, Bedwell J, MacRobert AJ, Krasner N, Phillips D, Bown SG (1992) Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 66: 452–462
MacRobert A J, Bown SG, Phillips D (1989) What are the ideal photoproperties for a sensitizer? In: Photosensitizing compounds: their chemistry, biology and clinical use. Wiley, Chichester, pp 4–16
Malik Z, Djaldetti M (1979) 5-aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. Cell Differ 8: 223–233
Marriott J (1968) Regulation of porphyrin synthesis. Biochem Soc Sympo 28: 61–74
Moan J, Sommer S (1985) Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK-3025 cells. Cancer Res 45: 1608–1610
Moan J, Berg K, Kvam E, Western A, Malik Z, Ruck A, Schneckenburger H (1989) Intracellular localization of photosensitisers. In: Photosensitizing compounds: their chemistry, biology and clinical use. Wiley, Chichester, pp 95–107
Monnier Ph, Savary M, Fontoliet Ch, Wagnieres G, Chatelain A, Cornaz P, Depeursinge Ch, van den Bergh H (1990) Photodetection and photodynamic therapy of ‘early’ squamous cell carcinomas of the pharynx, oesophagus and tracheobronchial tree. Lasers Med Sci 5: 149–169
Moss S, Calam J (1992) Helicobacter pylori and peptic ulcers: the present position. Gut 33: 289–292
Nelson JS, Liaw LH, Berns MW (1987) Tumor destruction in photodynamic therapy. Photochem Photobiol 46: 829–835
Patrice T, Foultier MT, Yactayo S, Adam F, Galmiche JP, Douet MC, Le Bodic L (1990) Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci 35: 545–552
Popat S, Vogel J, Wagner U, Biersack J, Krebs D, Schmidt S (1992) Morphological analysis after PDT with antibody-guided phthalocyanines ( Abstract ). Lasers Med Sci 7: 174
Potter WR, Mang TS, Dougherty TJ (1987) The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitiser. Photochem Photobiol 46: 97–101
Raab O (1900) Uber die Wirkung fluorescierender Stoffe auf Infusorien. Z Biol 39: 524–546
Rassmussen-Taxdal DS, Ward GE, Figge FHJ. (1955) Fluorescence of human lymphatic and cancer tissue following high doses of intravenous hematoporphyrin. Cancer 8: 78–81
Razum N, Balchum OJ, Profio E, Carstens F (1987) Skin photosensitivity: duration and intensity following intravenous hematoporphyrin derivatives, HpD and DHE. Photochem Photobiol 46: 925–928
Rimington C (1966) Porphyrin and haem biosynthesis and its control. Acta Med Scand 179 (Suppl 445): 11–24
Roberts WG, Smith KM, McCullough JL, Berns MW (1989) Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem Photobiol 49: 431–438
Schmidt S, Wagner U, Popat S, Schultes B, Spaniol S, Biersack J, Krebs D (1992) Clinical results with phthalocyanines ( Abstract ). Lasers Med Sci 7: 204
Schwartz SK, Absolon K, Vermund H (1955) Some relationship of porphyrins, x-rays and tumours. Univ Minn Med Bull 27: 7–8
Sima AAF, Kennedy JC, Balkeslee D, Robertson DM (1981) Experimental porphyric neuropathy: a preliminary report. Can J Neurol Sci 8: 105–114
Stern SJ, Flock ST, Small S, Thomsen S, Jacques S (1990). Photodynamic therapy with chloroaluminum sulfonated phthalocyanine in the rat window chamber. Am J Surg 160: 360–364
Svaasand LO (1984) Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors. In: Doiron DR, Gomer CJ (eds) Porphyrin localisation and treatment of tumors. Liss, New York, pp 91–114
Tajiri H, Daikuzono N, Joffe SN, Oguro Y (1987) Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 33: 88–90
Tralau CJ, Barr H, Sandeman DR, Barton T, Lewin MR, Bown SG (1987) Aluminum sulfonated phthalocyanine distribution in rodent tumours of the colon, brain, and pancreas. Photochem. Photobiol 46: 777–781
Tralau CJ, Young AR, Walker NPJ, Vernon DI, MacRobert AJ, Brown SB, Bown SG (1989) Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and sulphonated phthalocyanine (AlSPc): a comparative study. Photochem Photobiol 49: 305–312
Von Tappeiner H, Jesionek A (1903) Therapeutische Versuche mit fluorescierenden Stoffen. Münch Med Wochenschr 47: 2042–2044
Von Tappeiner H, Jodlbauer A (1907) Die sensibilisierende Wirkung fluorescierender Sub-stanzen. Gesammelte Untersuchungen über die photodynamische Erscheinung. Vogel, Leipzig
Weishaupt KR, Gomer CJ, Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36: 2326–2329
Wolf P, Kerl H (1991) Photodynamic therapy in patients with xeroderma pigmentosum. Lancet 337: 1613–1614
Zandomeneghi M, Festa C, Angeletti CA, Menconi G, Sicuro T, Cozzani I (1988) Detection of near-infrared porphyrin fluorescence excited in experimental animal tumours by the HeNe laser. Lasers Med Sci 3: 99–102
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Loh, C.S., Bown, S.G. (1993). Photodynamic Therapy of Gastric Malignancies: Current Status and Future Prospects. In: Domschke, W., Konturek, S.J. (eds) The Stomach. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78176-6_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-78176-6_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56613-7
Online ISBN: 978-3-642-78176-6
eBook Packages: Springer Book Archive